
Bio-Path Holdings BPTH
Quartalsbericht 2025-Q3
hinzugefügt 13.01.2026
Bio-Path Holdings P/CF 2011-2026 | BPTH
P/CF Jährlich Bio-Path Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.255 | -0.0381 | -2.54 | -1.39 | -2.03 | -0.196 | -2.73 | -10.2 | -25.1 | -51.2 | -135 | -9.99 | -10.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.0381 | -135 | -19.3 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 4.72 | 0.11 % | $ 756 M | ||
|
Cabaletta Bio
CABA
|
-2.16 | $ 3.35 | 2.76 % | $ 337 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.03 | -0.66 % | $ 4.99 M | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 333.44 | -1.76 % | $ 43.7 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.69 | 1.93 % | $ 8.88 B | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-0.799 | $ 7.81 | -10.64 % | $ 77.2 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Esperion Therapeutics
ESPR
|
-42.9 | $ 2.16 | 5.37 % | $ 449 M | ||
|
Evogene Ltd.
EVGN
|
-2.68 | $ 0.82 | -0.12 % | $ 27.9 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Forte Biosciences
FBRX
|
-6.59 | $ 32.09 | -1.02 % | $ 416 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 21.24 | -0.65 % | $ 993 M | ||
|
Galapagos NV
GLPG
|
-8.78 | $ 29.07 | 0.66 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
4.08 | $ 29.04 | -0.07 % | $ 18.6 B | ||
|
GT Biopharma
GTBP
|
-0.201 | $ 0.38 | -2.88 % | $ 2.1 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 99.63 | 1.24 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Hoth Therapeutics
HOTH
|
-1.14 | $ 0.71 | 9.78 % | $ 9.8 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Harmony Biosciences Holdings
HRMY
|
4.62 | $ 29.5 | 0.72 % | $ 1.7 B | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
4.92 | $ 1.55 | -0.96 % | $ 399 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.16 | 0.12 % | $ 445 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 24.32 | -3.07 % | $ 3.09 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
ImmuCell Corporation
ICCC
|
23.4 | $ 7.61 | -1.55 % | $ 68.7 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.48 | -0.34 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Immatics N.V.
IMTX
|
-6.15 | $ 10.88 | -0.68 % | $ 684 M | ||
|
Incyte Corporation
INCY
|
13.8 | $ 97.67 | -0.03 % | $ 19.1 B | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M |